More Globe Newswire

View Older Stories View Newer Stories

May 6, 2024 08:00AM Apogee Therapeutics to Participate at the 2024 Bank of America Healthcare Conference
May 6, 2024 08:00AM Safe & Green Holdings Corp Announces Pricing of $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules
May 6, 2024 08:00AM Enphase Energy Expands IQ8 Commercial Microinverter Deployments in North America
May 6, 2024 08:00AM LifeVantage to Participate in the Sidoti Micro Cap Conference
May 6, 2024 08:00AM ByteBitPro Exchange Announces Entry into International Markets and Establishes Collaborative Relationships with Local Financial Institutions in Brazil and Australia
May 6, 2024 08:00AM Gorilla and MTI Unveil Strategic Alliance to Pioneer Advanced Manufacturing Hub in Egypt
May 6, 2024 08:00AM Whitestone REIT Exposes New Information Revealing that Erez Nominee Bruce Schanzer Colluded with Terminated Whitestone Chairman and CEO James Mastandrea in a Failed Attempt to Acquire Whitestone
May 6, 2024 08:00AM Pacific Software Inc. Announces a Landmark Asset Acquisition from Dreamaderm Inc.
May 6, 2024 08:00AM GTG and ‘Wellworks for You’ sign B2B sales & marketing deal covering 750 employer groups and 2 million U.S. employees
May 6, 2024 08:00AM Sensus Healthcare Announces Sale of First SRT-100 Vision™ System to Asia
May 6, 2024 08:00AM Healthier Capital Founder and Former One Medical CEO Endorses Medeloop Amid Launch of New AI Research Agent
May 6, 2024 08:00AM Belite Bio Presents Additional Analysis from Phase 2 Study of Tinlarebant in Stargardt Disease at the ARVO Annual Meeting
May 6, 2024 08:00AM A Message to Our Valued Stakeholders - We're Here for the Long Haul
May 6, 2024 08:00AM Safe & Green Holdings Corp Announces Pricing of $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules
May 6, 2024 08:00AM The Children’s Place Reports Fourth Quarter and Full Year 2023 Results
May 6, 2024 08:00AM Rhythm Pharmaceuticals Presents Data from Phase 3 Pediatrics Trial at Pediatric Endocrine Society Annual Meeting
May 6, 2024 08:00AM Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2024
May 6, 2024 08:00AM Fate Therapeutics to Webcast Conference Call Reporting First Quarter 2024 Financial Results and Operational Updates
May 6, 2024 08:00AM Krystal Biotech Announces First Quarter 2024 Financial Results and Provides Business Updates
May 6, 2024 08:00AM RYVYL to Announce First Quarter 2023 Financial Results on Tuesday, May 14, 2024
May 6, 2024 08:00AM The Vita Coco Company to Participate in the Goldman Sachs Global Staples Forum
May 6, 2024 08:00AM Panbela Announces Issuance of New Patent in the US and Canada; Patent is for Claims of a Fixed Dose Combination of Eflornithine and Sulindac
May 6, 2024 08:00AM HAProxy Enterprise 2.9 Sets the Security Standard for Application Delivery
May 6, 2024 08:00AM Duos Technologies Group Sets First Quarter 2024 Earnings Call for Monday, May 13, 2024 at 4:30 PM ET
May 6, 2024 08:00AM aTyr Pharma to Present at Upcoming Investor Conferences
May 6, 2024 08:00AM Biora Therapeutics to Present Clinical Data on Device Function of the NaviCap™ Oral Delivery Platform at Digestive Disease Week 2024
May 6, 2024 08:00AM Iterum Therapeutics to Report First Quarter 2024 Financial Results on May 13, 2024
May 6, 2024 08:00AM Arqit Sets First Half 2024 Conference Call for Monday, May 20, 2024 at 11:00 a.m. ET
May 6, 2024 08:00AM Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts
May 6, 2024 08:00AM Sagimet Biosciences Announces Appointment of Thierry Chauche as Chief Financial Officer
May 6, 2024 08:00AM Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference
May 6, 2024 08:00AM Processa Pharmaceuticals to Participate in the EF Hutton Annual Global Conference
May 6, 2024 08:00AM New Funding from The Allstate Foundation Will Expand Youth-Led Service in Multiple States
May 6, 2024 08:00AM Real-World, Long-Term Data Demonstrate Sustained Benefits of Aquablation Therapy for Men with Benign Prostatic Hyperplasia
May 6, 2024 08:00AM Fulcrum Therapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Monday, May 13, 2024, at 8:00 a.m. ET
May 6, 2024 08:00AM Fingerprint Cards AB (publ) signs patent license agreement with major global firm, the first of its kind in the company’s history
May 6, 2024 08:00AM Scandinavian Tobacco Group A/S: Transactions in connection with share buy-back programme
May 6, 2024 08:00AM STMicroelectronics Announces Status of Common Share Repurchase Program
May 6, 2024 08:00AM Joni Sorsanen appointed CFO of Lassila & Tikanoja plc
May 6, 2024 08:00AM EDAP Announces Positive Final Results from the HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy During Plenary Session at the 119th American Urological Association (AUA)
May 6, 2024 08:00AM Allarity Therapeutics Exceeds Nasdaq’s Minimum Equity Requirement; Requests Voluntarily Withdrawal of Form S-1
May 6, 2024 07:59AM Lyra Therapeutics Reports Topline Results from Phase 3 ENLIGHTEN 1 Trial for LYR-210 in Chronic Rhinosinusitis
May 6, 2024 07:59AM Lophos Pharmaceuticals Corp. Enters Into Letter of Intent to Acquire the Assets of Magicactus.com
May 6, 2024 07:55AM Uniti Group Inc. Announces Private Offering of Senior Secured Notes
May 6, 2024 07:53AM Petrolympic holds a gold property in the Sudbury mining camp, in Ontario
May 6, 2024 07:50AM Garrett Motion Inc. Announces Proposed Private Offering of $500 Million of Senior Notes Due 2032
May 6, 2024 07:50AM Fairfax Announces the Passing of Eric Salsberg
May 6, 2024 07:49AM Divestment of NKT Photonics approved by the Danish Business Authority
May 6, 2024 07:45AM Trailbreaker Resources Receives Exploration Permit for Swan Target at Atsutla Gold Project
May 6, 2024 07:44AM Vow ASA: Invitation to Vow ASA first quarter 2024 presentation and Q&A
View Newer Stories View Older Stories